Publications by authors named "George Hutton"

Claim this Profile
C
Comparative effectiveness and safety of glatopa and copaxone in patients with multiple sclerosis.
Ning Lyu, Jieni Li, George J Hutton, Xinli Liu, Rajender R Aparasu

Mult Scler Relat Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of multiple sclerosis and disease-modifying therapy use in older adults in the United States, 2011-2021.
Jieni Li, George J Hutton, Rajender R Aparasu

Mult Scler· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection Risk Associated with High-Efficacy Disease-Modifying Agents in Multiple Sclerosis: A Retrospective Cohort Study.
Jieni Li, George J Hutton, Tyler J Varisco, Ying Lin, Ekere J Essien

Clin Pharmacol Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of high-efficacy and moderate efficacy disease-modifying agents in reducing the annualized relapse rates among multiple sclerosis patients in the United States.
Jieni Li, George J Hutton, Tyler J Varisco, Ying Lin, Ekere J Essien

Prev Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Intracranial Pressure in Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Torge Rempe, Aisha Elfasi, Samir Alkabie, Alison Christy, Elsa Rodriguez, George Hutton

Neurologist· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with the initiation of high-efficacy disease-modifying agents over moderate-efficacy disease-modifying agents in multiple sclerosis.
Jieni Li, George J Hutton, Tyler J Varisco, Ying Lin, Ekere J Essien

Mult Scler Relat Disord· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency, characteristics, predictors and treatment of relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
Torge Rempe, Elsa Rodriguez, Aisha Elfasi, Samir Alkabie, Mayra Montalvo Perero, George J Hutton

Mult Scler Relat Disord· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of oral disease-modifying agents and their adherence trajectories with annual relapses in multiple sclerosis.
Jagadeswara Rao Earla, Jieni Li, George J Hutton, John P Bentley, Rajender R Aparasu

Mult Scler Relat Disord· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing treatment switch among patients with multiple sclerosis: A machine learning approach.
Jieni Li, Yinan Huang, George J Hutton, Rajender R Aparasu

Explor Res Clin Soc Pharm· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis.
Jagadeswara Rao Earla, Jieni Li, George J Hutton, Michael L Johnson, Rajender R Aparasu

Pharmacotherapy· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Disparities in Multiple Sclerosis among Hispanic and Black Populations in the United States.
Michael Z Moore, Carlos A Pérez, George J Hutton, Hemali Patel, Fernando X Cuascut

Biomedicines· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis: A Clinical Update.
Carlos A Pérez, Fernando X Cuascut, George J Hutton

Neurol Clin· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life of patients with multiple sclerosis: Analysis of ten years of national data.
Jieni Li, Marjan Zakeri, George J Hutton, Rajender R Aparasu

Mult Scler Relat Disord· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FACTORS ASSOCIATED WITH SWITCHING FROM INJECTABLE TO ORAL DISEASE MODIFYING AGENTS AMONG PATIENTS WITH MULTIPLE SCLEROSIS.
Jieni Li, Soumya G Chikermane, Jagadeswara R Earla, George J Hutton, Rajender R Aparasu

Mult Scler Relat Disord· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Reasoning: A 57-Year-Old Man With Stepwise Progressive Paraparesis, Sensory Loss, Urinary Retention, and Constipation.
Samir Alkabie, Omar Tanweer, George J Hutton, Fernando X Cuascut

Neurology· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elsberg syndrome following acute immunosuppressive treatment for multiple sclerosis relapse.
Natasha A Choudhury, Rhaisa M Castrodad-Molina, George J Hutton, Fernando X Cuascut

Mult Scler Relat Disord· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescribing of disease modifying agents in older adults with multiple sclerosis.
Ashna Talwar, Jagadeswara R Earla, George J Hutton, Rajender R Aparasu

Mult Scler Relat Disord· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis.
Hyunwoo Lee, Kunio Nakamura, Sridar Narayanan, Robert A Brown, Richard A Nash, George J Hutton

Mult Scler Relat Disord· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fingolimod-related cryptococcal meningoencephalitis and immune reconstitution inflammatory syndrome in a patient with multiple sclerosis.
Fernando X Cuascut, Samir Alkabie, George J Hutton

Mult Scler Relat Disord· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis.
Jagadeswara Rao Earla, George J Hutton, J Douglas Thornton, Hua Chen, Michael L Johnson

Explor Res Clin Soc Pharm· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis.
Jagadeswara R Earla, George J Hutton, Douglas J Thornton, Hua Chen, Michael L Johnson

Pharmacotherapy· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The concurrence of multiple sclerosis and glioblastoma.
Samir Alkabie, Rhaisa Castrodad-Molina, Kent A Heck, Jacob Mandel, George J Hutton

Mult Scler Relat Disord· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis.
Jagadeswara R Earla, George J Hutton, J Douglas Thornton, Hua Chen, Michael L Johnson

Patient Prefer Adherence· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Sclerosis in a Multi-Ethnic Population in Houston, Texas: A Retrospective Analysis.
Vicki Mercado, Deepa Dongarwar, Kristen Fisher, Hamisu M Salihu, George J Hutton

Biomedicines· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records.
Jagadeswara R Earla, George J Hutton, J Douglas Thornton, Rajender R Aparasu

Mult Scler Relat Disord· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis